The findings that the majority of the patients who underwent second and third operable hepatectomy also had a low LC3 expression in both tumor and ANT tissues and that the loss-of-LC3 expression in both HCC and ANT tissues led to a high risk of HCC recurrence further support the use of LC3 as a prognostic factor for HCC recurrence. This evidence concerns the gene MAP1LC3A and neoplasm.